Keywords: Glycoprotein P, Methoxy Isobutyl Isonitrile Technetium Tc 99m, Diagnostic Agent, Radiopharmaceutical Agent, Bone Scintiscanning, Cancer Diagnosis, Cancer Staging, Diagnostic Accuracy, Diagnostic Imaging, Follow Up, Human, Letter, Multidrug Resistance, Multiple Myeloma, Priority Journal, Bone Tumor, Clinical Practice, Computer Assisted Tomography, Image Enhancement, Image Subtraction, Metastasis, Methodology, Nuclear Magnetic Resonance Imaging, Positron Emission Tomography, Practice Guideline, Single Photon Emission Computer Tomography, Bone Neoplasms, Physician, S Practice Patterns, Positron-Emission Tomography, Subtraction Technique, Technetium Tc 99m Sestamibi, Emission-Computed, Single-Photon, X-Ray Computed,
Affiliations: *** IBB - CNR ***
Università degli Studi di Napoli Federico II, Naples, Italy
Istituto di Biostrutture e Bioimmagini, CNR, Naples, Italy
Universit degli Studi di Napoli Federico II, Naples, Italy
References: Even-Sapir, E., Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities (2005) J Nucl Med, 46, pp. 1356-136
Pace, L., Catalano, L., Pinto, A.M., Different patterns of technetium-99m sestamibi uptake in multiple myeloma (1998) Eur J Nucl Med, 25, pp. 714-720
Catalano, L., Pace, L., Califano, C., Detection of focal myeloma lesions by technetium-99m-sestaMIBI scintigraphy (1999) Haematologica, 84, pp. 119-124
Balleari, E., Villa, G., Garre, S., Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: A useful tool for the identification and follow-up of myeloma bone disease (2001) Haematologica, 86, pp. 78-84
Svaldi, M., Tappa, C., Gebert, U., Technetium-99m-sestamibi scintigraphy: An alternative approach for diagnosis and follow-up of active myeloma lesions after high-dose chemotherapy and autologous stem cell transplantation (2001) Ann Hematol, 80, pp. 393-397
Alexandrakis, M.G., Kyriakou, D.S., Passam, F., Koukouraki, S., Karkavitsas, N., Value of Tc-99m sestamibi scintigraphy in the detection of bone lesions in multiple myeloma: Comparison with Tc-99m-ethylene diphosphonate (2001) Ann Hematol, 80, pp. 349-353
Fonti, R., Del Vecchio, S., Zannetti, A., Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma (2004) Cancer Biother Radiopharm, 19, pp. 165-170
Alexandrakis, M. G., Kyriakou, D. S., Passam, F., Koukouraki, S., Karkavitsas, N., Value of Tc-99m sestamibi scintigraphy in the detection of bone lesions in multiple myeloma: Comparison with Tc-99m-ethylene diphosphonate (2001) Ann Hematol, 80, pp. 349-353
Use of Tc-99m-Sestamibi scintigraphy in multiple myeloma
Not available.
Use of Tc-99m-Sestamibi scintigraphy in multiple myeloma
No results.
Use of Tc-99m-Sestamibi scintigraphy in multiple myeloma
Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R * 3. 0 T perfusion MR imaging(694 views) Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812. Impact Factor:0.023 ViewExport to BibTeXExport to EndNote